Author

Jayson Fernando

Observed names: Fernando, J, J Fernando

Observed institutions: Hackensack University Medical Center, St. George's University

OpenAlex ID: A5078137654

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Overlapping public health crises during the coronavirus disease pandemic

2021 · Nilanga Aki Bandara, Ricky Jhauj, et al. · World Journal of Emergency Medicine · 7

Severe anemia may not be a contraindication to debridement in a Jehovah’s witness patient with necrotizng fasciitis of the lower extremity – A case report

2019 · Chinwe Ogedegbe, Jayson Fernando, et al. · International Journal of Surgery Case Reports · 4

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

Works count: 7

Citation count: 103

H-index: 4

I10-index: 3